Terbinafine and Trimethoprim Interaction

Drug interaction information between Terbinafine and Trimethoprim.

Terbinafine and Trimethoprim have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Terbinafine and Trimethoprim. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Terbinafine

Allylamine Antifungal

Drug B

Trimethoprim

Dihydrofolate Reductase Inhibitor

How They Interact

Terbinafine does not significantly change how the body handles trimethoprim.

FDA Label Information

The influence of terbinafine on the pharmacokinetics of fluconazole, cotrimoxazole (trimethoprim and sulfamethoxazole), zidovudine or theophylline was not considered to be clinically significant.

Frequently Asked Questions

What SPL severity band is on file for Terbinafine + Trimethoprim?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Trimethoprim has 22 labeled pairs on file vs Terbinafine's 17. In the minor band specifically: Terbinafine has 16 (also Ketoconazole, Fluconazole, Cyclosporine, Rifampin); Trimethoprim has 18 (also Metformin, Glipizide, Warfarin, Methotrexate).

What mechanism field is on file for Terbinafine and Trimethoprim?

Terbinafine does not significantly change how the body handles trimethoprim.

Trimethoprim carries more major-labeled pairs than Terbinafine

SPL source-record counts only. This page's band is minor · classes on file: Terbinafine (Allylamine Antifungal); Trimethoprim (Dihydrofolate Reductase Inhibitor).

Trimethoprim has 1 major-labeled pair vs Terbinafine's 0. This page itself is in the minor band, not the major band.

Terbinafine

0 major · 1 moderate · 16 minor · 17 total

Trimethoprim

1 major · 3 moderate · 18 minor · 22 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.